Compounds useful as inhibitors of PDE4 in the treatment of diseases
regulated by the activation and degranulation of eosinophils, especially
asthma, chronic bronchitis, and chronic obstructive pulmonary disease, of
the formula: wherein the substituents are as defined in the
specification.